IP Library Granted Patent US 8,542,123
Granted Patent B2
US 8,542,123 · App. 13/564,479 · Granted Sep 24, 2013

Multi-mode communication ingestible event markers and systems, and methods of using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,542,123
App. No.
13/564,479
Granted
Sep 24, 2013
Kind
B2
Abstract

Aspects of the invention include multi-mode communication ingestible event marker devices. Ingestible event marker devices of the invention include an ingestible component comprising a conductive communication module and at least one additional non-conductive communication module. The non-conductive communication module may be integrated with the ingestible component or at least a portion or all of the non-conductive communication module may be associated with a packaging component of the ingestible event marker device. Additional aspects of the invention include systems that include the devices and one or more receivers, as well as methods of using the same.

Claims (38)

1. A method, comprising:

detecting at least one of a first signal and a second signal from a device comprising:

an ingestible component comprising an integrated circuit comprising a conductive communication module configured to emit the first signal, wherein the first signal generated by the conductive communication module is a near field signal that is communicated via a conductive communication protocol that uses fluid as a conduction medium; and

at least a portion of a non-conductive communication module configured to emit the second signal.

2. The method of claim 1 , wherein the method includes detecting the first signal.

3. The method of claim 1 , wherein the method includes detecting the second signal.

4. The method of claim 1 , wherein the method includes detecting the first signal and the second signal.

5. A method comprising:

emitting at least one of a first signal or a second signal from a device comprising:

an ingestible component comprising an integrated circuit comprising a conductive communication module configured to emit the first signal, wherein the first signal generated by the conductive communication module is a near field signal that is communicated via a conductive communication protocol that uses fluid as a conduction medium; and

at least a portion of a non-conductive communication module configured to emit the second signal.

6. The method of claim 5 , wherein the method includes emitting the first signal.

7. The method of claim 5 , wherein the method includes emitting the second signal.

8. The method of claim 5 , wherein the method includes emitting the first signal and the second signal.

9. A method, comprising:

transmitting a signal between a non-conductive communication module and a receiver, wherein the non-conductive communication module is a component of a device comprising:

an ingestible component comprising an integrated circuit comprising a conductive communication module, wherein the conductive communication module generates a near field signal that is communicated via a conductive communication protocol that uses fluid as a conduction medium; and

the non-conductive communication module.

10. The method of claim 9 , wherein the receiver is a component chosen from a system selected from the group consisting of manufacturing systems, supply chain management systems and health care management systems.

11. The method of claim 10 , wherein the receiver is a component of a manufacturing system.

12. The method of claim 11 , wherein the manufacturing system is a high-throughput manufacturing system.

13. The method of claim 11 , wherein the signal is transmitted from the device to the receiver.

14. The method of claim 11 , wherein the signal is transmitted from the receiver to the device.

15. The method of claim 10 , wherein the receiver is a component of a supply chain management system.

16. The method of claim 15 , wherein the signal is transmitted from the device to the receiver.

17. The method of claim 15 , wherein the signal is transmitted from the receiver to the device.

18. The method of claim 10 , wherein the receiver is a component of a health care management system.

19. The method of claim 18 , wherein the signal is transmitted from the device to the receiver.

20. The method of claim 18 , wherein the signal is transmitted from the receiver to the device.

21. A method comprising:

administering to a subject a device comprising:

an ingestible component comprising an integrated circuit comprising a conductive communication module configured to emit the first signal, wherein the first signal generated by the conductive communication module is a near field signal that is communicated via a conductive communication protocol that uses fluid as a conduction medium; and

at least a portion of a non-conductive communication module configured to emit the second signal.

22. The method of claim 21 , wherein the method further comprises receiving the first signal at a receiver.

23. The method of claim 22 , wherein the method further comprises determining historical information for the ingestible component from the received first signal.

24. The method of claim 21 , wherein the ingestible component includes an active pharmaceutical agent.

25. The method of claim 24 , wherein the ingestible component comprises a physiologically acceptable vehicle.

26. The method of claim 25 , wherein the physiologically acceptable vehicle is configured as a tablet or capsule.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2022
From: PROTEUS DIGITAL HEALTH, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 058868/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2022
From: OTSUKA AMERICA PHARMACEUTICAL, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 058868/0612 →
CHANGE OF NAME Recorded Nov 2, 2012
From: PROTEUS BIOMEDICAL, INC.
To: PROTEUS DIGITAL HEALTH, INC.
Reel/Frame 029228/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2012
From: ROBERTSON, TIMOTHY; ZDEBLICK, MARK
To: PROTEUS BIOMEDICAL, INC.
Reel/Frame 029221/0909 →